CRISPR Therapeutics (CRSP) Appoints Siva Sakhamuri As Chief Technical Officer
Yahoo Finance · Nov 3, 2026 · Crispr Therapeutics AG (CRSP)
CRISPR Therapeutics (NasdaqGM:CRSP) appointed Siva Sakhamuri, Ph.D., as Chief Technical Officer, according to a recent company announcement. Dr. Sakhamuri brings experience leading technical operations and manufacturing functions at established biotechnology enterprises focused on complex biologics. His background includes work on gene editing and RNA based therapies as well as oversight of regulatory submissions and commercial launches. The appointment of Dr. Siva Sakhamuri as Chief...
Not investment advice. Headline and summary only, not a full reprint.